Volume 30, Issue 6 987 p. 987
Short Report

Unsuccessful treatment attempt: Cord blood stem cell transplantation in a patient with Niemann–Pick disease type A

C. F. Morel

C. F. Morel

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8 Canada

Search for more papers by this author
A. Gassas

A. Gassas

Division of Haematology and Oncology, Blood and Marrow Transplant Program, The Hospital for Sick Children, Toronto, Ontario, Canada

Search for more papers by this author
J. Doyle

J. Doyle

Division of Haematology and Oncology, Blood and Marrow Transplant Program, The Hospital for Sick Children, Toronto, Ontario, Canada

Search for more papers by this author
J. T. R. Clarke

Corresponding Author

J. T. R. Clarke

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8 Canada

[email protected]

Search for more papers by this author
First published: 25 October 2007
Citations: 12

Communicating editor: Robert Steiner

Online citation: JIMD Short Report #092 (2007) Online

Electronic Supplementary Material:

The online version of this article (doi:10.1007/s10545-007-0700-1) contains supplementary material, which is available to authorized users.

Summary

Niemann–Pick disease type A (NP-A; OMIM 257200) is an autosomal recessive lysosomal storage disorder caused by deficiency of acid sphingomyelinase and resulting in accumulation of sphingomyelin, unesterified cholesterol, and other complex lipids in many tissues. It is characterized by failure to thrive, hepatosplenomegaly, and a rapidly progressive neurodegenerative course culminating in death by 3 years of age. There is no known effective treatment. We report the case of a prenatally diagnosed girl who underwent cord blood stem cell transplantation (CBSCT) at 3 months of age. She was neurologically intact at the time of CBSCT. Hepatosplenomegaly, was detected at 6 weeks of age; the splenomegaly resolved following CBSCT. Recovery was complicated by graft-versus-host disease. She subsequently developed and continues to show marked global developmental delay, generalized hypotonia, and signs of neurological regression, despite continued engraftment. Bilateral cherry red spots were detected at 10 months of age, 7 months post-CBSCT. Although she is doing better than her affected brother, she shows little overall benefit from CBSCT.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.